PCR Webinars on Stents, Scaffolds and Drug-coated Balloons

Upcoming Webinars

Webinars On Demand

How to use DCB in coronary bifurcations

How to use DCB in coronary bifurcations

Stent or Leave: considerations for a successful DCB PCI

Stent or Leave: considerations for a successful DCB PCI

DCB digital crosstalk: practice patterns for patients with diabetes and diffuse disease in Asia

DCB digital crosstalk: practice patterns for patients with diabetes and diffuse disease in Europe

A patient with ISR: what is the role of DCB today?

Drug-coated balloons as a first choice for patients with de novo lesions: pros and cons

Drug-coated balloons as a first choice for patients with de novo lesions: pros and cons

Bioresorbable scaffolds - new evidence and clinical applications

Bioresorbable scaffolds - new evidence and clinical applications

Treating patients with drug-coated balloons – what is the optimal result?

Treating patients with drug-coated balloons – what is the optimal result?

Minimal-metal PCI: a drug-coated balloon philosophy combined with selective lesion stenting where necessary - the hybrid approach

Minimal-metal PCI

Why and when to use DCB?

Why and when to use DCB?

Bioresorbable scaffolds - back to the future? Pros and Cons

Bioresorbable scaffolds - back to the future? Pros and Cons

DCB PCI in clinical practice: negotiating the learning curve

DCB PCI in clinical practice: negotiating the learning curve

DCB, what you expect to see at follow-up from a “different” approach to PCI

Webinar Medtronic DCB - Second module of the series

DCB, when and how to use. A discussion with the experts

Webinar Medtronic DCB - First module of the series

Drug Coated Balloons 2021-2022

Drug Coated Balloons Coronary Intervention Series

How and when should I consider Drug Coated Balloons to treat de novo lesions?

How and when should I consider Drug Coated Balloons to treat de novo lesions ?

#1 - How should I treat a patient with in-stent restenosis ?

How should I treat a patient with in-stent restenosis ?

A patient with diabetes and diffuse coronary disease – how should I treat small vessels?

A patient with diabetes and diffuse disease – how should I treat small vessels?

The SYNTAX II strategy: integrating best practices in complex PCI

The SYNTAX II strategy: integrating best practices in complex PCI